TIMP1 and Hepatic fibrosis: In the context of liver diseases, OSM enhances the expression of tissue inhibitor of metalloproteinases 1 (TIMP1), suppresses fibrinolytic activity in hepatic stellate cells, and facilitates the proliferation of myofibroblasts, thereby contributing to the pathogenesis of liver fibrosis (38).